Another week, another entrepreneurial journey for you! This week it's Andreas Halner, president and co-founder of Oxford Cancer Analytics (OXcan), who chats to our director, Megan Morys-Carter, about the company's inception, what makes the technology so revolutionary and the ever increasing success OXcan have been met with recently. Since we recorded this episode, OXcan have secured $11 million in Series A funding, and we congratulate Andreas and his team on such incredible success!

Follow TheHill here: https://www.linkedin.com/company/thehill

Sign up for our newsletter: https://mailchi.mp/thehill/mailing-list